GraftAssureBeyond's analysis on GraftAssure2026-07-16 — Medicare's expanded coverage for donor-derived cell-free DNA testing removes a key reimbursement barrier, accelerating adoption of iMDx's GraftAssure assay in transplant diagnosticsBrowse the full archive →